Suchergebnisse - "Singh, Parminder"

PubPharm (11)

1

Multicenter comparison of transcatheter aortic valve implantation with the self-expanding ACURATE neo2 versus Evolut PRO transcatheter heart valves

enthalten in: Clinical research in cardiology : official journal of the German Cardiac Society | 2024

von Rheude, T. | Pellegrini, C. | Landt, M. | +16

2

Talimogene laherparepvec in combination with ipilimumab versus ipilimumab alone for advanced melanoma : 5-year final analysis of a multicenter, randomized, open-label, phase II trial

enthalten in: Journal for immunotherapy of cancer | 2023

von Chesney, J. | Puzanov, I. | Collichio, F. | +13

3

Cabozantinib in combination with atezolizumab in patients with metastatic castration-resistant prostate cancer : results from an expansion cohort of a multicentre, open-label, phase 1b trial (COSMIC-021)

enthalten in: The Lancet. Oncology | 2022

von Agarwal, N. | McGregor, B. | Maughan, B. | +16

CommentIn: Nat Rev Urol. 2022 Aug;19(8):454. - PMID 35831541

4

Optimal pathological response after neoadjuvant chemotherapy for muscle-invasive bladder cancer : results from a global, multicentre collaboration

enthalten in: BJU international | 2021

von Ravi, P. | Pond, G. | Diamantopoulos, L. | +19

CommentIn: J Urol. 2022 Dec;208(6):1347-1349. - PMID 36111981

5

Multi-centre randomised controlled trial comparing arthroscopic hip surgery to physiotherapist-led care for femoroacetabular impingement (FAI) syndrome on hip cartilage metabolism : the Australian FASHIoN trial

enthalten in: BMC musculoskeletal disorders | 2021

von Hunter, D. | Eyles, J. | Murphy, N. | +24

6

Effect of saroglitazar 2 mg and 4 mg on glycemic control, lipid profile and cardiovascular disease risk in patients with type 2 diabetes mellitus : a 56-week, randomized, double blind, phase 3 study (PRESS XII study)

enthalten in: Cardiovascular diabetology | 2020

von Krishnappa, M. | Patil, K. | Parmar, K. | +42

CommentIn: Diabetes Metab Syndr. 2020 Nov-Dec;14(6):2093. - PMID 33147557

7

PSMA ADC monotherapy in patients with progressive metastatic castration-resistant prostate cancer following abiraterone and/or enzalutamide : Efficacy and safety in open-label single-arm phase 2 study

enthalten in: The Prostate | 2020

von Petrylak, D. | Vogelzang, N. | Chatta, K. | +18

8

Randomized, Open-Label Phase II Study Evaluating the Efficacy and Safety of Talimogene Laherparepvec in Combination With Ipilimumab Versus Ipilimumab Alone in Patients With Advanced, Unresectable Melanoma

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2018

von Chesney, J. | Puzanov, I. | Collichio, F. | +15

9

Protocol for a multi-centre randomised controlled trial comparing arthroscopic hip surgery to physiotherapy-led care for femoroacetabular impingement (FAI) : the Australian FASHIoN trial

enthalten in: BMC musculoskeletal disorders | 2017

von Murphy, N. | Eyles, J. | Bennell, K. | +24

10

Cisplatin-based first-line therapy for advanced urothelial carcinoma after previous perioperative cisplatin-based therapy

enthalten in: Clinical genitourinary cancer | 2015

von Necchi, A. | Pond, G. | Giannatempo, P. | +12